期刊文献+

化疗对结肠癌Th1和Th2类细胞因子基因表达的影响及意义 被引量:7

The Influence and Significance of Chemotherapy for the Gene Expression of Th1 and Th2 Cytokines in Colon Carcinoma
下载PDF
导出
摘要 目的:探讨结肠癌Th1和Th2类细胞因子的基因表达水平及化疗对其表达的影响。方法:采用RT-PCR技术,检测35例正常人、30例结肠息肉和67例结肠癌患者及结肠癌组化疗后外周血单个核细胞(PBMC)Th1和Th2类细胞因子mRNA表达水平。结果:正常对照组及结肠息肉组Th1和Th2类细胞因子基因表达呈阴性或基本不表达。结肠癌组IL-4、IL-6、IL-10mRNA表达水平显著高于正常对照组及结肠息肉组(P<0.05);IFN-!无阳性表达(0/67),IL-2则仅有3例阳性表达。化疗后Th1类细胞因子表达增强,Th2类细胞因子的表达则减弱(P<0.05)。结论:结肠癌患者呈Th2类细胞因子强势表达,细胞免疫受抑,化疗可纠正Th1/Th2的失衡状态,甚至使Th2类向Th1类漂移。 To observe the influence of chemotherapy on the switch between Thl and Th2 cytokines in colon carcinoma. Methods: The gene expression of Thl and Th2 cytokines was detected by reverse transcription polymerase chain reaction (RT-PCR) in 35 normal controls, 30 cases with benign colon polyps and 67 patients with colon carcinoma before and after chemotherapy. Results: Thl and Th2 cytokines were negative in peripheral blood from those with benign polyps and the normal controls. The mRNA expression of IL-4, IL-6, and IL-10 in PBMCs from patients with colon carcinoma was significantly higher than in patients with benign polyps or the normal controls (P〈0.05). IFN-γ expression was not detected in any patients (0/67) before treatment, and the detection of IL-2 expression was only 3/67. After chemotherapy, the expression of Thl and Th2 cytokines in colon carcinoma was significantly changed. There was also a significant enhancement in IFN-γ and IL-2 expression paralleled by a substantial decrease in IL-4, IL-6, and IL-10. Conclusion: The expression of Thl cytokine was inhibited and there was a concomitant state of Th2 cytokine predominance in PBMCs from patients with colon carcinoma. Chemotherapy can convert the imbalanced state of Thl and Th2 cytokines present in colon carcinoma and make it incline more toward normal.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2006年第16期916-919,共4页 Chinese Journal of Clinical Oncology
基金 山东省卫生厅科研基金项目资助(编号:2001CA1DCB4)
关键词 结肠肿瘤 逆转录聚合酶链反应 细胞因子 化学治疗 Colon carcinoma Reverse transcription-polymerase chain reaction (RT-PCR)Cytokines Chemotherapy
  • 相关文献

参考文献10

  • 1刘杰,田志刚,冯进波,魏海明.人肿瘤细胞中Th2类细胞因子的强势表达[J].中华肿瘤杂志,1998,20(2):105-107. 被引量:50
  • 2Li R,Ruttinger D,Li R,et al.Analysis of the immunological microenvironment at the tumor site in patients with non-small cell lung cancer[J].Langenbecks Arch Surg,2003,388(6):406~412
  • 3Yamamura M,Modlin RL,Ohmen JD,et al.Local expression of anti-inflammatory cyyokines in cancer[J].Clin Invest,1993,91(3):1005~1010
  • 4魏海明,田志刚,刘杰,冯进波,孙汭.14种细胞因子基因检测方法的建立及初步临床应用[J].中华微生物学和免疫学杂志,2000,20(2):180-181. 被引量:38
  • 5Mosmann TR,Cherwinski H,Bond MW,et al.Two types of murine helper T cell clone.I.Definition according to profiles of lymphokine activities and secreted proteins[J].J Immunol,1986,136(7):2348~2357
  • 6姚新生.Th1与Th2研究概况及进展[J].国外医学(免疫学分册),2002,25(6):290-293. 被引量:26
  • 7Glimcher LH,Murphy KM.Lineage commitment in the immune system:the T helper lymphocyte grows up[J].Genes Dev,2000,14(14):1693 ~ 1711
  • 8Yamazaki K,Yano T,Kameyama T,et al.Clinical significance of serum Th1/Th2 cytokines in patients with pulmonary adenocarcinoma[J].Surgery,2002,131(1):236~241
  • 9Chechlinska M,Duma A,Swierkowska K,et al.Sera of lung cancer patients affect the release of Th1,Th2 and monocyte-derived cytokines,and the expression of IL-2Ralpha by normal,stimulated mononuclear cells[J].Cell Mol Biol Lett,2004,9(1):69~81
  • 10李岩,梁婧,刘文波,许晓群,赵跃然.化疗对胃癌Th1和Th2类细胞因子漂移的影响及临床意义[J].中华肿瘤杂志,2004,26(12):732-734. 被引量:20

二级参考文献26

  • 1Colantonio L, Recalde H,Sinigaglia F, et al.[J].J Immunol,2002,32(5): 1264-1273.
  • 2Ebner S, Hofer S,Nguyen. VA.[J].J Immunol,2002,168(12):6199-6207.
  • 3Albanesi C, Scarponi C, Cavani AA, et al. [J]. J Invest Dermatol, 2000,115(1) :81-87.
  • 4Stephensea CB, Rasooly R, Jiang X, et al. [J]. J Immunol, 2002,168(9) :4495-4503.
  • 5Weiner HL.[J].Microbes Infect,2001,3(11):947-954.
  • 6Nakanishi K,Yoshimoto T, Tsutsui H,et al.[J].Cytokine Growth Factor Rev,2001,12(1) :53-72.
  • 7Nakanishi K.[J].Kekkaku,2002,77(2):87-93.
  • 8Chirathaworn C, Kohlmeier JE, Tibbetts SA, et al. [J]. J Immunol, 2002,168(11) :5530-5537.
  • 9Shibaki A,Katz SI.[J].Exp Dermatol,2002,11(2):126-134.
  • 10Dieli F, Singh M, Spallek R, et al. [J].Scand J Immunol,2000,52(1) :96-102.

共引文献117

同被引文献179

引证文献7

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部